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Background & aims: Several studies have demonstrated that vegetarians and vegans have much lower
plasma concentrations of omega-3 fatty acids (i.e., docosahexaenoic and eicosapentaenoic acids) when
compared to those who eat ﬁsh. The purposes of this study were 1) to deﬁne the age and/or sex-speciﬁc
docosahexaenoic plus eicosapentaenoic acids levels in red blood cell membranes (expressed as a percent
of total fatty acids; hereafter the omega-3 index) in long-term vegans, and 2) to determine the effects of a
vegetarian omega-3 supplement (254 mg docosahexaenoic plus eicosapentaenoic acids/day for 4
months) on the omega-3 index.
Methods: A sample (n ¼ 165) of vegans was recruited, and their omega-3 index was determined using a
dried blood spot methodology. A subset of 46 subjects with a baseline omega-3 index of <4% was given a
vegetarian omega-3 supplement for 4 months and then retested.
Results: The mean  SD omega-3 index was 3.7  1.0% which was similar to that of a cohort of omnivores
(deployed US soldiers) from a recently-reported study. Among the vegan cohort, the index was signiﬁ-
cantly higher in females than males (3.9  1.0% vs. 3.5  1.0%; p ¼ 0.026) and was directly related to age
(p for trend ¼ 0.009). The omega-3 index increased from 3.1  0.6% to 4.8  0.8% (p ¼ 0.009) in the
supplementation study.
Conclusions: We conclude that vegans have low baseline omega-3 levels, but not lower than omnivores
who also consume very little docosahexaenoic and eicosapentaenoic acids. The vegans responded
robustly to a relatively low dose of a vegetarian omega-3 supplement.
 2014 The Authors. Published by Elsevier Ltd and European Society for Clinical Nutrition and
Metabolism. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/
licenses/by-nc-nd/3.0/).1. Introduction
The main omega-3 fatty acid in the vegan diet is alpha-linolenic
acid (ALA), which is derived from foods such as soybeans, ﬂaxseed
and walnuts. ALA is very sparingly and inefﬁciently converted into
the long-chain omega-3 fatty acids docosahexaenoic acid (DHA)
and eicosapentaenoic acid (EPA).1,2 Several studies have demon-
strated that vegetarians and vegans have much lower plasmaariance; ALA, alpha-linolenic
call; DHA, docosahexaenoic
noic acid; RBC EPA þ DHA,
3, Sioux Falls, SD 57107, USA.
s).
A, USA.
r Ltd and European Society for Clin
d/3.0/).concentrations of DHA and EPA when compared to those who eat
ﬁsh.3e6 Supplementation with ALA increases plasma EPA to a small
extent, but it has little effect on DHA.2,3
A substantial body of research (in essentially omnivorous pop-
ulations) over the past several decades has documented the health
beneﬁts of increased omega-3 fatty acid intakes, suggesting that
baseline levels could be considered deﬁcient.7 Because ﬁsh and ﬁsh
oils were, up until recently, the only concentrated sources of pre-
formed DHA and EPA, individuals who do not eat ﬁsh or ﬁsh oils
could be at risk of low omega-3 fatty acid status. Whether this
translates into increased risk for disease (e.g., cardiovascular) in
vegans is unknown as their risk is already lower than that of om-
nivores. A recent meta-analysis found a 29% reduction in risk for
death from ischemic heart disease and 18% reduction in risk for
cancer in vegetarians compared to non-vegetarians,8 and the EPIC-
Oxford study reported similar beneﬁts in British vegetarians.9 Until
randomized trials with omega-3 fatty acids are conducted inical Nutrition and Metabolism. This is an open access article under the CC BY-NC-ND
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levels of these nutrients will reduce risk for disease will remain
unanswered. Nevertheless, at our present state of knowledge, it is
possible that low omega-3 status does place vegetarians/vegans at
increased risk for disease, which then presents a dilemma for these
individuals.
There were 2 purposes of this study. The ﬁrst (Phase 1) was to
determine omega-3 status in long-term vegans and to investigate
age and/or sex-related differences. We also sought to compare a
vegan with an omnivore cohort with respect to omega-3 status. As
we were unable to recruit two cohorts simultaneously in this
investigation, we have used published data (also from our labora-
tory) from omnivores who met most of the same inclusion/exclu-
sion criteria as did the vegans.10 The second purpose was to
determine the extent to which omega-3 status can be improved in
vegans by the administration of a vegan DHA þ EPA supplement
(Phase 2). Throughout we have used DHA þ EPA content of red
blood cells (RBC) expressed as a percent of total RBC fatty acids
(hereafter called the omega-3 index11), as the biomarker of omega-
3 status.
2. Methods
2.1. Subjects
This study was approved by the University of San Diego Insti-
tutional Review Board. Subjects were recruited from vegan web-
sites (e.g., vegsource.com, vegnews.com, healthscience.org), with
an announcement directing interested individuals to a brief
screening questionnaire on the study website. To qualify for the
study subjects were required to be 20 years of age or older, vegan
(consuming no meat, ﬁsh, eggs or dairy) for at least one year and
currently not taking any essential fatty acid supplements. Subjects
who met these criteria were contacted by study staff and invited to
complete a consent form online (at nutritionalresearch.org). After
doing so subjects were enrolled in the study and received an email
with their personal identiﬁcation number and password to use to
complete the online study demographic questionnaire. This ques-
tionnaire included information on age, gender, height, weight, race/
ethnic group, education, and length of time on a vegan diet, and
nutritional supplements used currently and in the past year. In
addition to collecting a blood sample, participants were instructed
to complete 3 days of dietary recall online (described below).
Participants who completed the online consent form and study
questionnaire were sent an omega-3 index test kit by regular mail.
The kit contained a letter welcoming participants to the study and
giving general instructions for completing the study. The kit also
included blood sample collection instructions, all necessary sup-
plies, a sample collection cardwith study ID, and a test request form
and prepaid return envelope for the blood sample. Participants
were instructed to collect a drop of blood from a ﬁngerstick and
mail it immediately to the laboratory (OmegaQuant Analytics,
Sioux Falls, SD). The samples were analyzed on the day of arrival as
described below. (This is the same procedure that was used in the
omnivore study noted above.)
A total of 296 people ﬁlled out the screening questionnaire and
were qualiﬁed to participate in Phase 1 of the study. There were an
additional 619 who were qualiﬁed to participate but, because we
had reached the quota of 27 subjects per gender/age group (see
Section 2.4), these individuals were put on a waiting list. Of the 296
whowere originally qualiﬁed for the study, 59 did not complete the
online dietary survey within a period of two months. These in-
dividuals were notiﬁed that theywould be removed from the study,
and those on the waiting list in the corresponding sex*age groups
were invited to participate. Recruitment occurred betweenFebruary and August of 2012. Enrolled participants received a $20
gift certiﬁcate from a national department store chain.
In Phase 2 of the study we invited a sample of Phase 1 partici-
pants who had been tested early in Phase 1 andwho had an omega-
3 index of 4.0% or below to take a vegan omega-3 supplement for 4
months. Of 61 invited individuals, 48 chose to participate. These
individuals were sent a 4-month supply of a vegan omega-3 sup-
plement (Life’s DHA plus EPA, DSM Nutritional Products, Inc., Par-
sippany, NJ) providing 172 mg DHA and 82 mg EPA per 0.75 mL.
They were instructed to take this amount daily via a graduated
bottle dropper. The blood collection protocol used in Phase 1 was
repeated after 4 months.
2.2. Fatty acids
The omega-3 index home test kit was used to measure subjects’
essential fatty acid levels in a dried blood spot as previously
described.10 Brieﬂy, fatty acids (n ¼ 24) are identiﬁed using capil-
lary column gas chromatography with an internal-standard-based,
three-point calibration curve approach. Upon receipt in the labo-
ratory, paper punches of dried blood are transferred to a reaction
vial. Fatty acid methyl esters are generated with boron triﬂuoride
for 10 min at 100 C, extracted into hexane after the addition of
water and analyzed by gas chromatography by using a GC2010 Gas
Chromatograph (Shimadzu Corporation, Columbia, MD) equipped
with a SP2560, 100-m column (Supelco, Bellefonte, PA). Fatty acids
are identiﬁed by comparison with a standard mixture of fatty acids
(GLC 727, Nucheck Prep, Elysian, MN). The omega-3 index (an
erythrocyte-speciﬁc metric) is calculated from the dried blood spot
EPA þ DHA value using an equation determined from a study
comparing these two values from 49 subjects. The correlation co-
efﬁcient between RBC and dried blood spot EPA þ DHA was 0.96
(p< 0.0001). The laboratory coefﬁcient of variation for the omega-3
index is 5e6%.
2.3. Dietary assessments
In Phase 1 dietary intake datawere collected and analyzed using
the Automated Self-Administered 24-h Recall (ASA24) system,
version 1, developed by the National Cancer Institute, Bethesda,
MD. ASA24 is a freely available, web-based software tool.12 It con-
sists of a respondent web site used by participants to enter recall
data and a researcher web site to manage study logistics and obtain
analyses. The format and design of the Respondent Web site are
modeled on the interviewer-administered Automated Multiple
Pass Method 24-h recall developed by the US Department of
Agriculture. Nutrient intakes were calculated by the ASA24 pro-
gram based on the USDA’s Food and Nutrient Database for Dietary
Studies. Participants were instructed to complete at least two, and if
possible three, days of dietary recall with a separation of 2e3 days
between each recall. Regular reminders were sent to participants
who did not complete the recalls within a month of enrollment in
the study.
The ASA24 database did not include chia and hemp seeds, two
food sources of ALA that might be consumed on a regular basis by
vegans. These were therefore included in the online study survey,
and the ALA provided was calculated as the grams of hemp/chia
seed per teaspoon frequency perweek grams ALA per teaspoon.
2.4. Statistical analysis
In phase 1, participants were initially stratiﬁed into ﬁve age
categories by gender (20e39, 40e59, 60e69, 70e79, and 80þ).
Recruitment by internet proved to be difﬁcult for those aged 70 and
above, therefore the age categories of 70e79 and 80þ were
Table 1
Demographic characteristics for participants in phase 1 (N ¼ 167).
Female Male
Age
20e39 25 21
40e59 26 26
60e69 19 23
70þ 17 10
Education
HS or less (11e12) 8 4
Some college (13e16) 36 43
Post-college (17þ) 43 33
Race
Asian 2 3
Black 1 0
Hispanic 3 3
Paciﬁc Islands 0 1
White 81 73
Total 87 80
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age/gender group would provide 80% power to detect an effect size
of 0.4 (Cohen’s f) when testing the interaction term between sex
and age group (4 degree of freedom test) for the omega-3 index in a
two-way factorial analysis of variance (ANOVA) with a two-sided
signiﬁcance level of 0.05 (G*Power software v. 3.1.3). One of our
cells had a sample size of 10 while the rest of the groups ranged
between 17 and 26.
Descriptive statistics were computed for key study variables and
included means, and standard deviations for continuous variables,
and frequencies and percentages for categorical ones. Years of
formal educationwas censored at 17 for those having greater than a
college education. Race/ethnicity is self-reported as Asian, Black,
Hispanic, Paciﬁc Islander, or White.
Those with at least one day of dietary recall were included in
analyses involving dietary variables. These variables were averaged
across the available days (ranging from 1 to 5 days). Study partic-
ipants were included in the analysis if they completed the survey,
and contributed data for the blood analysis and/or the dietary
recall.
To address the question of whether therewere differences in the
omega-3 index by age group, one-way analysis of variance was
utilized, and the linear trend in mean omega-3 index across the age
groups was formally assessed though a statistical contrast. To
formally assess the question of whether there were mean differ-
ences in the omega-3 index by gender, a two-sample independent
groups t-test was utilized]. Two-way ANOVA examined the ques-
tion of whether mean omega-3 index varied by both age group and
gender, and their interaction, as well as the linear trend across the
age groups. Spearman correlation coefﬁcients were computed and
tested to determine whether there were associations between
omega-3 index and both dietary intake of ALA and body mass in-
dex; analysis of covariance was used to assess these relationships
controlling for age.
To address the question of whether there are differences in the
omega-3 index between this vegan cohort and a group of omni-
vores (also not taking omega-3 supplements whose blood was
analyzed using the same laboratorymethods as those usedwith the
vegans), we used data from 78 US soldiers deployed in Iraq.10 Only
blood fatty acids present at 0.5% or more of total in either cohort
were included in the analysis. Fatty acid percentages were
compared by two-sample t-test.
All statistical analysis was generated using SAS software,
(Version 9.3, SAS Institute Inc., Cary, NC, USA). The signiﬁcance level
was set at two-sided 0.05, and the comparison of fatty acid levels
with the US soldiers utilized a Bonferroni adjustment accounting
for the number of fatty acids reported (0.05/15 fatty
acids ¼ 0.0036).
3. Results
3.1. Phase 1
Of those who qualiﬁed and were eligible, 178 completed the
online consent form and survey, 167 sent in a blood sample and 146
completed at least one 24-h dietary recall. The omega-3 index was
available from 166 participants (one blood sample was not
analyzed for technical reasons). The analysis that examined the
relationship between dietary intake of ALA and blood levels of
omega-3 fatty acids included 141 subjects who had completed the
survey, sent in their blood sample and completed at least one 24-
h dietary recall. Dietary recalls (n ¼ 143) were available for 1e5
days (2.7  0.9 days).
Fifty-two percent of participants were female and 92% were
white (Table 1). Age ranged from 22 to 85 years (years). Sevenpercent had a high school education or less, while 46% had post-
college graduate education. Body mass index was 22.7  3.7 kg/
m2 (range 16.4e41.2) and years as a vegan ranged from 1 to 52
(12.8  10.7).
The mean omega-3 index was 3.7  1.0% (Table 2), and it was
signiﬁcantly higher in females than males (females ¼ 3.9%  1.0%
vs. males ¼ 3.5%  1.0%; p ¼ 0.026). The omega-3 index was
directly and linearly related with age, with means of 3.5%, 3.6%,
4.0%, and 4.0% for the youngest to the oldest age groups (linear
trend p ¼ 0.009; Fig. 1). Further adjusted for dietary ALA as the
sole covariate in the regression model, the linear trend between
age group and the omega-3 index became non-signiﬁcant
(p ¼ 0.18). In two-way ANOVA, the gender by age group interac-
tion was not signiﬁcant (p ¼ 0.13), and the main effects model
supported the gender (p ¼ 0.023) effect and age group linear trend
(p ¼ 0.010).
Intakes of EPA and DHA from dietary recalls were very low (EPA
1.5  3.5 and DHA 2.8  10.1 mg/day), whereas the intake of ALA
averaged 3.40  2.54 g/day. The omega-3 index was not correlated
with dietary ALA (r ¼ 0.075, p ¼ 0.53), nor with BMI (r ¼ 0.074,
p ¼ 0.34). These non-signiﬁcant relationships persisted when
controlling for age (p¼ 0.95 and p¼ 0.81, respectively). Therewas a
strong relationship between age and ALA intake (r ¼ 0.23,
p ¼ 0.003).
Demographics and levels of 14 blood fatty acids were compared
between the vegans and the US soldiers. The subset of vegans
included in this comparison was a mean of 7 years older than the
soldiers and had more years of education (Table 3). The vegans had
signiﬁcantly (p < 0.003) higher levels of EPA and docosapentaenoic
acid (22:5n3, DPA) than the soldiers. Vegan DHA levels, however,
were non-signiﬁcantly lower (p ¼ 0.015; did not reach the adjusted
level of 0.003) as was the omega-3 index (p ¼ 0.95). As for the
omega-6 fatty acids, arachidonic acid (20:4n6) was slightly lower in
the vegans, but linoleic acid (18:2n6) was similar between groups.
Trans fatty acids (18:1 and 18:2 isomers) were lower in the vegans
(see Table 4).3.2. Phase 2
Pre- and post-results were available for 46 individuals (2 post-
blood tests were lost in the mail). The omega-3 index increased
from 3.1  0.6% to 4.8  0.8% (p < 0.001; Fig. 2). Of 46 subjects with
a pre-supplementation omega-3 index of <4%, 40 (87%) achieved
an Index of >4% after supplementation.
Table 2
Baseline blood fatty acidsa and the Omega-3 Index in 166 vegan subjects.
Fatty acids Mean SD
14:0 0.69% 0.44%
16:0 22.41% 1.65%
18:0 14.38% 1.02%
18:1trans 0.42% 0.25%
18:1n9 17.51% 2.00%
18:2trans 0.53% 0.41%
18:2n6 19.19% 2.65%
18:3n3 0.55% 0.31%
20:3n6 2.15% 0.55%
20:4n6 11.68% 1.89%
20:5n3 0.63% 0.29%
22:4n6 2.16% 0.57%
22:5n3 2.00% 0.49%
22:6n3 2.44% 0.84%
Omega-3 Indexb 3.73% 1.02%
a Includes only fatty acids present at >0.4% of total fatty acids.
b The omega-3 index is the estimated erythrocyte EPAþ DHA level and is derived
from whole blood DHA þ EPA levels by application of a regression equation as
described previously.10
Table 3
Demographic characteristics for the male vegans, 20e54 years of age [matching the
age range of the comparator group of US Soldiers deployed in Iraq10].
Vegans (n ¼ 40) Soldiers (n ¼ 78) P-value
Age (mean  SD) 38  9 31  7 0.0002
Education <0.0001
High school or less 2 (5%) 14 (18%)
Some college 26 (65%) 64 (82%)
Post-college 12 (30%) 0
Race NS
Asian 3 (8%) 1 (1%)
Black 0 (0%) 4 (5%)
Hispanic 1 (3%) 5 (6%)
White 36 (90%) 68 (87%)
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This study surveyed the omega-3 index in long-term vegans and
examined sex- and age-related differences. Assuming an omega-3
index of <4% to be undesirable, 64% of the cohort fell into this
category, 27% were <3% and 1% was <2%. Thus, a substantial
number of vegan subjects have low omega-3 status. Interestingly,
two subjects had an index of >8%, the proposed cardioprotective
level,11 underscoring the marked metabolic variability possible
between individuals. We observed an increase in the index with
age, which has been observed before in omnivore populations13
and has typically been explained by increased ﬁsh intake with
aging. This obviously cannot be the case in the present cohort ofFig. 1. Linear trend in baseline omega-3 index by age group for participants in Phase 1.
P for trend ¼ 0.009.vegans. The explanation for this observation here is unclear, but the
fact that the inclusion of the ALA intake into the model eliminated
the signiﬁcant relationship between age and the omega-3 index
suggests that increasing ALA intakes with age may have contrib-
uted to the correlation between age and the index. Whether the
higher ALA intake was responsible for the higher omega-3 index
cannot be known from these cross sectional observations. We
found that women had higher omega-3 indexes than men. This too
has been reported previously and is presumed to be due to
enhanced synthesis of EPA and DHA from ALA in pre-menopausal
women.14 Overall, the omega-3 index was not correlated with di-
etary ALA intake, suggesting that post-intake processes (e.g., ab-
sorption, synthetic enzyme activities, clearance, etc.) are more
determinants of the omega-3 index than dietary ALA.
There have been several previous head-to-head studies
comparing omega-3 status in omnivores (meat-eaters) and vegans/
vegetarians, and most were reviewed by Sanders in 2009.6 Some
have used plasma or plasma lipid classes4,5 whereas others have
used RBCs.3,15e18 In the largest sample reported to date, plasma
levels of EPA þ DHA (percent of total fatty acids) were 1.0% in 232
vegans and 2.4% in 196 meat-eaters.5 In the four prior studies that
measured RBC EPA þ DHA in vegans, levels averaged between 1%
and 3.8% (Table 5) compared with 3.7% in the present US study. As
all these studies were performed in different countries in different
labs, dietary, genetic, laboratory methodologic, and/or de-
mographic/lifestyle factors may be responsible for these differ-
ences. Typically, RBC EPA þ DHAwas about 50e60% lower than in a
comparator group of omnivores.Table 4
Blood fatty acid proﬁles (percent of total fatty acids) for the male vegans, 20e54
years of age [matching the age range of the comparator group of US Soldiers
deployed in Iraq10].
Fatty acids Vegans (n ¼ 40) Soldiers (n ¼ 78)
14:0 0.76  0.64 0.83  0.36
16:0 22.39  1.44 23.21  1.27*
18:0 14.28  1.08 14.38  0.83
18:1trans 0.38  0.25 1.26  0.55*
18:1n9 17.95  1.88 16.16  1.33*
18:2trans 0.51  0.33 0.90  0.18*
18:2n6 18.70  2.68 18.50  1.91
18:3n3 0.49  0.21 0.32  0.13*
20:3n6 2.08  0.42 1.97  0.42
20:4n6 11.95  1.90 12.94  1.65
20:5n3 (EPA) 0.56  0.22 0.40  0.18*
22:4n6 2.44  0.49 2.34  0.44
22:5n3 2.02  0.48 1.51  0.27*
22:6n3 (DHA) 2.28  0.70 2.61  0.65
Omega-3 Indexa 3.48  0.81 3.47  0.72
*p < 0.0033, Bonferroni adjustment 0.05/15 tests.
a Calculated erythrocyte EPA þ DHA content.
Fig. 2. The effects of 254 mg/d of omega-3 fatty acids in 46 vegan subjects on the omega-3. The omega-3 index and other selected blood fatty acids measured before (black) and
after (gray) 12 weeks of supplementation. Abbreviations: EPA, eicosapentaenoic acid; DHA, docosahexaenoic acid; DPA; docosapentaenoic acid; ALA, alpha-linolenic acid; LA,
linoleic acid; ARA, arachidonic acid; Omega-3 Index, the sum of EPA þ DHA. *p < 0.05; **p < 0.001.
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here (3.7%) was lower than that seen in other non-vegan cohorts in
which RBC fatty acids were reported. For example, it was 4.7% in
about 160,000 presumably omnivorous outpatients in the US hav-
ing blood tested at a clinical laboratory.13 Average indexes in other
US cohorts were 5.7% in the Framingham Offspring Study,19 and
4.6% in a group of about 900 patients with stable coronary dis-
ease.20 In another cohort of 21 non-ﬁsh oil supplementing, low ﬁsh
intake outpatients from Kansas City the average omega-3 index
was 3.4%.21
Here we included as a comparator population a group of 78 US
service members (virtually all males) deployed in Iraq who were
eating Army rations (deﬁnitely not vegetarian cuisine). They were
chosen because they were tested using the same dried blood spot
method as was used here and because they met similar inclusion/
exclusion criteria as the vegans (except, of course, being vegan).
This afforded an opportunity to compare full blood fatty acidTable 5
Comparison of red blood cell EPA þ DHA (percent of total fatty acids) in vegans and
controls in previous studies.
Population Vegans Controls Description of controls
British16 2.0% (n ¼ 22) 6.4% (n ¼ 22) “not on special diets”; matched
on age, sex, height, SES status,
ethnicity
Austrian3 1.0% (n ¼ 37) 2.2% (n ¼ 23) Self-deﬁned omnivore by
questionnaire
Dutch17 2.3% (n ¼ 12) 4.5% (n ¼ 76) “adult omnivores”
Finnish18 3.8% (n ¼ 8) 8.1% (n ¼ 11) “normal mixed diet”; controls
reported an average of 2 ﬁsh
meals per week
US (present
study)
3.5% (n ¼ 40) 3.5% (n ¼ 78) US Soldiers deployed in Iraq10patterns not just the omega-3 index. We found that EPA and DPA
(the latter being an elongation product of the former) were both
signiﬁcantly higher in the vegans than in the soldiers, but DHA (and
the omega-3 index) were not different. In other words, absent a
simultaneous, direct comparison between vegans and omnivores
using the same dried blood spot methodology, it appears that
vegans are no different from omnivores who also consume very
little omega-3. Based on this comparison, the vegans may even
produce more EPA (and DPA), from their presumably higher ALA
intake. It should be noted that the vegan subset was older andmore
well-educated than the soldier comparators, and both of these
factors have been associated with higher omega-3 status.13,22
Perhaps not surprisingly, trans fatty acid levels were lower in the
vegan cohort, presumably due to a higher intake of products con-
taining partially-hydrogenated vegetable oils in Army rations.
In Phase 2, we found that a relatively low dose of EPA þ DHA
(243 mg per day) signiﬁcantly raised the omega-3 index. The mean
absolute increase here was 1.7% over 4 months. This compares
favorably to an observed increase of 1.8% in a group of 23 omnivores
given 300 mg EPA þ DHA for 5 months.23 In another study, 850 mg
of EPA þ DHA ethyl esters raised the omega-3 index by 1.5% after 2
months of supplementation.24 Although not head-to-head studies,
blood samples were measured using the same method in all 3 of
these studies. In a German study with an algal DHA-only supple-
ment, 940 mg/d for 2 months was reported to raise the omega-3
index from 4.8% to 8.4% in 87 vegetarians.15 All of these ﬁndings
suggest that vegans respond to supplemental omega-3 fatty acids
in the same way that omnivores do.
Omega-3 treatment reduces risk for CHD death25 but these data
are from omnivorous populations, and whether vegans would
derive similar beneﬁt is unclear. It is well-known that cardiovas-
cular risk in vegans/vegetarians is signiﬁcantly reduced compared
to omnivore controls,8,9 and thus at present, there is no direct
B. Sarter et al. / Clinical Nutrition 34 (2015) 212e218 217evidence that raising the omega-3 index would confer additional
health beneﬁts over and above their already-protective vegan diet.
More than the risk of cardiovascular disease, a concern raised by
these results is that chronic low omega-3 levels among vegans
could lead to depression26 or neurologic decline in later life.27 In a
large study of 800 military suicides, the risk of death was 62
percent higher in thosewith lowDHA levels.28 With increased DHA
demands of the baby, nursing vegan mothers may be at increased
risk for post-partum depression.
Epidemiological and animal studies also suggest that omega-3
fatty acids are protective against cognitive decline.29 Decreases in
plasma DHA are associatedwith cognitive decline in healthy elderly
and Alzheimer’s patients and higher DHA intake and plasma levels
are inversely correlated with increased relative risk of Alzheimer’s
disease.30 However, if started early enough in life and maintained
for sufﬁcient years, some evidence suggests that it may be pro-
tective. For example, Witte et al. showed that omega-3 supple-
mentation improved executive function31 in healthy elderly
subjects. A low omega-3 index was associated with poorer execu-
tive function in the cohort of soldiers included in this report.10
Higher levels of blood DHA are associated with greater cognitive
function scores and brain volume.31,32 The consistency of the
epidemiological ﬁndings suggests that a lifetime DHA insufﬁciency
may put vegans at increased risk for cognitive dysfunction.
Strengths of this study included a relatively large (compared
with past studies, Table 5) sample of US vegans, an objective
measure of omega-3 status, and the combination of both cross-
sectional and interventional components. The study also had
several imitations. We did not include a control group in Phase 2,
nor did we conduct analyses accounting for potential confounding
variables such as race, genetic polymorphisms, or concomitant
medication interactions. As noted earlier, a contemporaneous
comparison group of omnivores was not included. The sample was
self-selected and thus may not be truly representative of the pop-
ulation of interest. We also found the particular dietary intake
website we used was quite difﬁcult for many subjects to use. This
led to fewer average completions than the goal of three per subject.
Hence, our fatty acid intake data may be questionable although the
intakes we report are reasonable for vegans. There was no objective
measure of adherence to the supplementation guidelines in Phase
2. Since subjects were taking their omega-3 fatty acids by eye-
dropper, actual doses likely varied considerably, and how, exactly
the subjects consumed the dose of <1 mL per day is also unknown
(i.e., directly on the tongue, mixed in other foods, dispersed in juice,
etc.).
We conclude that a majority of long-term vegans appear to be
relatively deﬁcient in DHA and EPA, but whether this leads to
adverse health consequences is unclear. It is possible that low-dose
supplementation with algae-sourced DHA and EPA may mitigate
the potential adverse effects of deﬁciency in this population. All of
these issues require additional investigation.
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